Tag: NASDAQ:CLDX

Finance

Biotech Most Volatile: Celldex Therapeutics (NASDAQ:CLDX), Dyax Corp. (NASDAQ:DYAX), Insmed Incorporated (NASDAQ:INSM), Novavax (NASDAQ:NVAX)

Celldex Therapeutics Inc. (NASDAQ:CLDX) options contracts experienced a new 90-day record for call contracts where a total of 5,803 call contracts were traded in the busy trading session. The contract spread yielded a 0.58 put/call ratio where 1.7 call contracts were traded for each put contract. Celldex Therapeutics, Inc. (NASDAQ:CLDX) stock performance was 0.07% in last session and finished the day at $13.73. Traded volume … Continue reading Biotech Most Volatile: Celldex Therapeutics (NASDAQ:CLDX), Dyax Corp. (NASDAQ:DYAX), Insmed Incorporated (NASDAQ:INSM), Novavax (NASDAQ:NVAX)

Chris Lewis
Finance

Top Losers: Advanced Micro Devices (NYSE:AMD), Sprint Corporation (NYSE:S), Yingli Green Energy (NYSE:YGE), Celldex Therapeutics (NASDAQ:CLDX)

Many sources from the GPU industry indicated last month that neither Advanced Micro Devices, Inc. (NYSE:AMD), nor Nvidia Corp. plan to make major GPU introductions at least till late in 2014, or maybe even early 2015. Advanced Micro Devices, Inc. (NYSE:AMD) stock performance was -5.19% in last session and finished the day at $3.65. Traded volume was 34.43million shares in the last session and the … Continue reading Top Losers: Advanced Micro Devices (NYSE:AMD), Sprint Corporation (NYSE:S), Yingli Green Energy (NYSE:YGE), Celldex Therapeutics (NASDAQ:CLDX)

Adam Keintzel
Finance

Biotech Losers: BioMarin Pharmaceutical Inc. (NASDAQ:BMRN), Celldex Therapeutics, Inc. (NASDAQ:CLDX), Novavax, Inc. (NASDAQ:NVAX), Biogen Idec Inc (NASDAQ:BIIB)

BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) and AstraZeneca (NYSE:AZN) are among those companies with late stage drugs in trials that specifically target genetic mutations. Both BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)’s BMN-673, which is in phase 3 trials, and Astra’s Olaparib, which may get the EU’s go-ahead in ovarian cancer this year, address a mutation of the BRCA 1 and BRCA 2 gene that is often associated with breast … Continue reading Biotech Losers: BioMarin Pharmaceutical Inc. (NASDAQ:BMRN), Celldex Therapeutics, Inc. (NASDAQ:CLDX), Novavax, Inc. (NASDAQ:NVAX), Biogen Idec Inc (NASDAQ:BIIB)

Jayne Crisman
BioTech

Medical Stocks in the News: Celldex Therapeutics (NASDAQ:CLDX), NeuroMetrix (NASDAQ:NURO)

Celldex Therapeutics (NASDAQ:CLDX) is lower Monday afternoon after its net loss  widened and revenue declined compared to the year-ago period. Results were better than Wall Street’s expectations but could not fend off sellers. In early afternoon action, shares of the biopharmaceutical company are down 11% at $26.15 and traded earlier as low as $25.76. The stock moves within a 52-week range of $9.13 – $38.84. Celldex … Continue reading Medical Stocks in the News: Celldex Therapeutics (NASDAQ:CLDX), NeuroMetrix (NASDAQ:NURO)

Kevin Long
BioTech

Biotech Bearish Stocks: Questcor Pharmaceuticals (NASDAQ:QCOR), ACADIA Pharmaceuticals (NASDAQ:ACAD), Idera Pharmaceuticals (NASDAQ:IDRA), Celldex Therapeutics (NASDAQ:CLDX)

Citron exposes explosive findings behind the true components of Questcor Pharmaceuticals Inc (NASDAQ:QCOR) flagship drug HP Acthar Gel. Questcor Pharmaceuticals Inc. (NASDAQ:QCOR) stock performance was -9.96% in last session and finished the day at $60.75. Traded volume was 0.00 shares in the last session and the average volume of the stock remained 2.86 million shares. The beta of the stock remained 0.95. Questcor Pharmaceuticals Inc. … Continue reading Biotech Bearish Stocks: Questcor Pharmaceuticals (NASDAQ:QCOR), ACADIA Pharmaceuticals (NASDAQ:ACAD), Idera Pharmaceuticals (NASDAQ:IDRA), Celldex Therapeutics (NASDAQ:CLDX)

John Bellich